Diagnosis |
Identification or confirmation of disease |
Drug response |
Evaluation of sequence variation influencing an individual’s reaction to specific medications, as in a pharmacogenetic test. Excludes immune-mediated adverse drug reactions (dose-independent drug allergies). |
Monitoring |
Periodic or continuous evaluation of a disease or condition over time, including a patient’s response to medical treatment. |
Mutation confirmation |
Re-evaluation of a genetic test result to assess the validity of the initial result. For example, research test results or results from another laboratory. |
Pre-implantation genetic diagnosis |
Genetic testing performed on a small number of cells from a human embryo before uterine implantation as part of assisted reproduction procedures. |
Pre-symptomatic |
Genetic analysis of an asymptomatic or unaffected individual who is at risk of a specific genetic disorder. |
Risk assessment |
Evaluation of the likelihood of developing a specific condition based on genetic risk. Includes carrier testing in affected families. |
Screening |
Evaluation of a target population to identify a subgroup affected by a genetic condition or that have the potential to transmit the trait to their offspring. Includes newborn screening, ethnicity-based screening and pre-conceptual genetic testing. |